Bausch + Lomb Corporation Profile Avatar - Palmy Investing

Bausch + Lomb Corporation

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that…
Medical - Instruments & Supplies
CA, Vaughan [HQ]

Cash Flow Statements

6 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
763.00 799.00 522.00 873.00 345.00 -17.00
Operating Cash (Net)
763.00 799.00 522.00 873.00 345.00 -17.00
Accounts Receivable
-9.00 -21.00 77.00 -107.00 -95.00 -121.00
Accounts Payable
-19.00 78.00 -144.00 163.00 189.00 245.00
Working Capital
- - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-74.00 -186.00 -256.00 -214.00 -215.00 -2,109.00
Capital Expenditure
-101.00 -180.00 -259.00 -209.00 -175.00 -181.00
Purchases of Investments
-7.00 -16.00 -6.00 -19.00 -62.00 -17.00
Sale/Maturity of Investment
7.00 10.00 9.00 14.00 22.00 16.00
Property, Plant, Equipment (P&PE)
-101.00 -180.00 -259.00 -209.00 -175.00 -181.00
Acquisitions (Net)
- - 6.00 6.00 16.00 45.00 -1,941.00
Other Investing Activities
27.00 -6.00 -6.00 -16.00 -45.00 14.00
Financing Activities
Used Cash (Net)
-665.00 -606.00 -232.00 -712.00 -81.00 -2,078.00
Debt Repayment
- - - - - - -28.00 -13.00 -161.00
Dividends Paid
- - - - - - - - - - - -
Common Stock
- - - - - - - - - - 10
Other Financing Activities
-665.00 -606.00 -232.00 -712.00 94.00 2,239.00
Cash Balances
Begin of Period
172.00 188.00 192.00 238.00 177.00 380.00
End of Period
188.00 192.00 238.00 177.00 380.00 334.00
Change
16.00 4.00 46.00 -61.00 203.00 -46.00
Non-Cash Balances
Depreciation and Amortization
495.00 469.00 442.00 415.00 379.00 382.00
Stock Based Compensation
- - 50.00 50.00 62.00 62.00 74.00
Other
28.00 56.00 9.00 59.00 -2.00 72.00
Highlighted metrics
Free Cash Flow (FCF)
662.00 619.00 263.00 664.00 170.00 -198.00
Cash Conversion Cycle (CCC)
- - 159.00 193.00 152.00 132.00 186.00
Invested Capital
- - - - - - - - - - - -
Other Operating Inflows/Outflows
End of BLCO's Analysis
CIK: 1860742 CUSIP: 071705107 ISIN: CA0717051076 LEI: - UEI: -
Secondary Listings
BLCO has no secondary listings inside our databases.